Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter F Thall

Showing results (71-80 of 190) with videos related to

Pageof 19
Sort By:
Biometrics|December 24, 2002
Seamlessly expanding a randomized phase II trial to phase IIILurdes Y T Inoue, Peter F Thall, Donald A Berry
Journal of the American Statistical Association|December 27, 2016
Bayesian Nonparametric Estimation for Dynamic Treatment Regimes with Sequential Transition TimesYanxun Xu, Peter Müller, Abdus S Wahed, et al.
Journal of the American Statistical Association|November 11, 2014
Using Data Augmentation to Facilitate Conduct of Phase I-II Clinical Trials with Delayed OutcomesIck Hoon Jin, Suyu Liu, Peter F Thall, et al.
Bayesian Analysis|September 30, 2017
A Decision-Theoretic Comparison of Treatments to Resolve Air Leaks After Lung Surgery Based on Nonparametric ModelingYanxun Xu, Peter F Thall, Peter Müller, et al.
Journal of the Royal Statistical Society. Series C, Applied Statistics|August 31, 2019
Bayesian non-parametric survival regression for optimizing precision dosing of intravenous busulfan in allogeneic stem cell transplantationYanxun Xu, Peter F Thall, William Hua, et al.
Cancers|August 26, 2022
A Causal Framework for Making Individualized Treatment Decisions in OncologyPavlos Msaouel, Juhee Lee, Jose A Karam, et al.
Computational Statistics & Data Analysis|October 17, 2017
Bayesian variable selection for a semi-competing risks model with three hazard functionsAndrew G Chapple, Marina Vannucci, Peter F Thall, et al.
Biostatistics (Oxford, England)|December 18, 2007
Monitoring late-onset toxicities in phase I trials using predicted risksB Nebiyou Bekele, Yuan Ji, Yu Shen, et al.
Journal of the Royal Statistical Society. Series C, Applied Statistics|April 15, 2010
A Bayesian hierarchical mixture model for platelet derived growth factor receptor phosphorylation to improve estimation of progression-free survival in prostate cancerSatoshi Morita, Peter F Thall, B Nebiyou Bekele, et al.
Journal of the American Statistical Association|November 5, 2014
Optimizing Sedative Dose in Preterm Infants Undergoing Treatment for Respiratory Distress SyndromePeter F Thall, Hoang Q Nguyen, Sarah Zohar, et al.
Pageof 19

Showing results (71-80 of 190) with videos related to

Sort By:
Pageof 19
Biometrics|December 24, 2002
Seamlessly expanding a randomized phase II trial to phase IIILurdes Y T Inoue, Peter F Thall, Donald A Berry
Journal of the American Statistical Association|December 27, 2016
Bayesian Nonparametric Estimation for Dynamic Treatment Regimes with Sequential Transition TimesYanxun Xu, Peter Müller, Abdus S Wahed, et al.
Journal of the American Statistical Association|November 11, 2014
Using Data Augmentation to Facilitate Conduct of Phase I-II Clinical Trials with Delayed OutcomesIck Hoon Jin, Suyu Liu, Peter F Thall, et al.
Bayesian Analysis|September 30, 2017
A Decision-Theoretic Comparison of Treatments to Resolve Air Leaks After Lung Surgery Based on Nonparametric ModelingYanxun Xu, Peter F Thall, Peter Müller, et al.
Journal of the Royal Statistical Society. Series C, Applied Statistics|August 31, 2019
Bayesian non-parametric survival regression for optimizing precision dosing of intravenous busulfan in allogeneic stem cell transplantationYanxun Xu, Peter F Thall, William Hua, et al.
Cancers|August 26, 2022
A Causal Framework for Making Individualized Treatment Decisions in OncologyPavlos Msaouel, Juhee Lee, Jose A Karam, et al.
Computational Statistics & Data Analysis|October 17, 2017
Bayesian variable selection for a semi-competing risks model with three hazard functionsAndrew G Chapple, Marina Vannucci, Peter F Thall, et al.
Biostatistics (Oxford, England)|December 18, 2007
Monitoring late-onset toxicities in phase I trials using predicted risksB Nebiyou Bekele, Yuan Ji, Yu Shen, et al.
Journal of the Royal Statistical Society. Series C, Applied Statistics|April 15, 2010
A Bayesian hierarchical mixture model for platelet derived growth factor receptor phosphorylation to improve estimation of progression-free survival in prostate cancerSatoshi Morita, Peter F Thall, B Nebiyou Bekele, et al.
Journal of the American Statistical Association|November 5, 2014
Optimizing Sedative Dose in Preterm Infants Undergoing Treatment for Respiratory Distress SyndromePeter F Thall, Hoang Q Nguyen, Sarah Zohar, et al.
Pageof 19